Multiplex immunohistochemistry/immunofluorescence is superior to tumor mutational burden and PD‐L1 immunohistochemistry for predicting response to anti‐PD‐1/PD‐L1 immunotherapy

Detalles Bibliográficos
Autor principal: Hu, Weixian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Editorials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938747/
https://www.ncbi.nlm.nih.gov/pubmed/31722117
http://dx.doi.org/10.1111/1759-7714.13233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938747/
https://www.ncbi.nlm.nih.gov/pubmed/31722117
http://dx.doi.org/10.1111/1759-7714.13233

Ejemplares similares